DK2523958T3 - Carboxylsyrederivater med en 2,5,7-substitueret oxazolopyrimidinring - Google Patents
Carboxylsyrederivater med en 2,5,7-substitueret oxazolopyrimidinringInfo
- Publication number
- DK2523958T3 DK2523958T3 DK11700098.4T DK11700098T DK2523958T3 DK 2523958 T3 DK2523958 T3 DK 2523958T3 DK 11700098 T DK11700098 T DK 11700098T DK 2523958 T3 DK2523958 T3 DK 2523958T3
- Authority
- DK
- Denmark
- Prior art keywords
- oxazolopyrimide
- substituted
- ring
- carboxylic acid
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10305036 | 2010-01-13 | ||
| PCT/EP2011/050298 WO2011086077A1 (de) | 2010-01-13 | 2011-01-12 | Carbonsäurederivate mit einem 2,5,7-substituierten oxazolopyrimidinring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2523958T3 true DK2523958T3 (da) | 2014-03-31 |
Family
ID=42111309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11700098.4T DK2523958T3 (da) | 2010-01-13 | 2011-01-12 | Carboxylsyrederivater med en 2,5,7-substitueret oxazolopyrimidinring |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8748436B2 (da) |
| EP (1) | EP2523958B1 (da) |
| JP (1) | JP5844277B2 (da) |
| KR (1) | KR101759117B1 (da) |
| CN (1) | CN103097392B (da) |
| AR (1) | AR079981A1 (da) |
| AU (1) | AU2011206613B2 (da) |
| BR (1) | BR112012017485A2 (da) |
| CA (1) | CA2799474C (da) |
| DK (1) | DK2523958T3 (da) |
| ES (1) | ES2453956T3 (da) |
| HK (1) | HK1180314A1 (da) |
| IL (1) | IL220706A (da) |
| MX (1) | MX2012007870A (da) |
| MY (1) | MY156960A (da) |
| PT (1) | PT2523958E (da) |
| RU (1) | RU2560876C2 (da) |
| SG (1) | SG182477A1 (da) |
| TW (1) | TWI478929B (da) |
| UY (1) | UY33177A (da) |
| WO (1) | WO2011086077A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI485153B (zh) | 2010-01-13 | 2015-05-21 | Sanofi Aventis | ２，５，７－經取代唑并嘧啶衍生物 |
| AU2011206615B2 (en) * | 2010-01-14 | 2015-03-19 | Sanofi | Carboxylic acid derivatives having A 2,5-substituted oxazolopyrimidine ring |
| CN102834399B (zh) * | 2010-01-14 | 2015-04-22 | 赛诺菲 | 具有2,5-取代的*唑并嘧啶环的杂环羧酸衍生物 |
| MY159857A (en) | 2010-01-14 | 2017-02-15 | Sanofi Sa | 2,5-substituted oxazolopyrimidine derivatives |
| US9321787B2 (en) | 2011-07-07 | 2016-04-26 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
| EP2990055B1 (en) | 2013-04-26 | 2019-06-05 | Kyoto University | Composition comprising a sphingosine-1-phosphate receptor 1 agonist for inhibiting formation and/or enlargement of cerebral aneurysm or for shrinking it |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3679682A (en) * | 1970-04-23 | 1972-07-25 | Fmc Corp | CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES |
| CA2523739A1 (en) | 2003-04-25 | 2004-11-11 | University College Cardiff Consultants Limited | Heterocyclic compounds for use in the treatment of viral infections |
| PE20050158A1 (es) * | 2003-05-19 | 2005-05-12 | Irm Llc | Compuestos inmunosupresores y composiciones |
| US7060697B2 (en) * | 2003-05-19 | 2006-06-13 | Irm Llc | Immunosuppressant compounds and compositions |
| US7855193B2 (en) * | 2005-11-23 | 2010-12-21 | Epix Pharmaceuticals, Inc. | S1P receptor modulating compounds and use thereof |
| WO2007109334A2 (en) | 2006-03-21 | 2007-09-27 | Epix Delaware, Inc. | Sip receptor modulating compounds and use thereof |
| TW201000099A (en) * | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
| EP2318415B1 (en) | 2008-07-15 | 2013-02-20 | Sanofi | Oxazolopyrimidines as edg-1 receptor agonists |
| AU2011206615B2 (en) | 2010-01-14 | 2015-03-19 | Sanofi | Carboxylic acid derivatives having A 2,5-substituted oxazolopyrimidine ring |
| CN102834399B (zh) | 2010-01-14 | 2015-04-22 | 赛诺菲 | 具有2,5-取代的*唑并嘧啶环的杂环羧酸衍生物 |
| MY159857A (en) | 2010-01-14 | 2017-02-15 | Sanofi Sa | 2,5-substituted oxazolopyrimidine derivatives |
-
2011
- 2011-01-11 AR ARP110100074A patent/AR079981A1/es unknown
- 2011-01-11 UY UY0001033177A patent/UY33177A/es not_active Application Discontinuation
- 2011-01-11 TW TW100100890A patent/TWI478929B/zh not_active IP Right Cessation
- 2011-01-12 ES ES11700098.4T patent/ES2453956T3/es active Active
- 2011-01-12 PT PT117000984T patent/PT2523958E/pt unknown
- 2011-01-12 JP JP2012548408A patent/JP5844277B2/ja not_active Expired - Fee Related
- 2011-01-12 CA CA2799474A patent/CA2799474C/en not_active Expired - Fee Related
- 2011-01-12 CN CN201180013730.XA patent/CN103097392B/zh not_active Expired - Fee Related
- 2011-01-12 BR BR112012017485A patent/BR112012017485A2/pt not_active IP Right Cessation
- 2011-01-12 MX MX2012007870A patent/MX2012007870A/es active IP Right Grant
- 2011-01-12 AU AU2011206613A patent/AU2011206613B2/en not_active Ceased
- 2011-01-12 WO PCT/EP2011/050298 patent/WO2011086077A1/de active Application Filing
- 2011-01-12 EP EP11700098.4A patent/EP2523958B1/de active Active
- 2011-01-12 DK DK11700098.4T patent/DK2523958T3/da active
- 2011-01-12 KR KR1020127021140A patent/KR101759117B1/ko active IP Right Grant
- 2011-01-12 RU RU2012134378/04A patent/RU2560876C2/ru not_active IP Right Cessation
- 2011-01-12 MY MYPI2012002590A patent/MY156960A/en unknown
- 2011-01-12 SG SG2012051207A patent/SG182477A1/en unknown
- 2011-01-12 US US13/521,827 patent/US8748436B2/en active Active
-
2012
- 2012-07-01 IL IL220706A patent/IL220706A/en not_active IP Right Cessation
-
2013
- 2013-06-27 HK HK13107551.1A patent/HK1180314A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL220706A0 (en) | 2012-08-30 |
| BR112012017485A2 (pt) | 2016-04-19 |
| ES2453956T3 (es) | 2014-04-09 |
| RU2560876C2 (ru) | 2015-08-20 |
| KR20120115397A (ko) | 2012-10-17 |
| KR101759117B1 (ko) | 2017-07-18 |
| US20130079357A1 (en) | 2013-03-28 |
| MY156960A (en) | 2016-04-15 |
| WO2011086077A1 (de) | 2011-07-21 |
| EP2523958B1 (de) | 2013-12-25 |
| HK1180314A1 (en) | 2013-10-18 |
| SG182477A1 (en) | 2012-08-30 |
| TWI478929B (zh) | 2015-04-01 |
| AU2011206613A1 (en) | 2012-08-02 |
| CN103097392B (zh) | 2015-05-13 |
| UY33177A (es) | 2011-08-31 |
| AR079981A1 (es) | 2012-03-07 |
| CN103097392A (zh) | 2013-05-08 |
| AU2011206613B2 (en) | 2015-04-02 |
| PT2523958E (pt) | 2014-03-27 |
| CA2799474A1 (en) | 2011-07-21 |
| JP2013517239A (ja) | 2013-05-16 |
| RU2012134378A (ru) | 2014-02-20 |
| TW201136940A (en) | 2011-11-01 |
| EP2523958A1 (de) | 2012-11-21 |
| CA2799474C (en) | 2018-02-20 |
| US8748436B2 (en) | 2014-06-10 |
| JP5844277B2 (ja) | 2016-01-13 |
| IL220706A (en) | 2015-06-30 |
| MX2012007870A (es) | 2012-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2552261T3 (da) | Propfilter med proprum med aromakugle | |
| DK2623507T3 (da) | Morpholinonukleinsyrederivat | |
| BR112013009843A2 (pt) | produção de biodestilado renovável | |
| BR112012031837A2 (pt) | triazolopiridinas substituídas | |
| FI20116102A (fi) | Ilmarengas | |
| DK2523958T3 (da) | Carboxylsyrederivater med en 2,5,7-substitueret oxazolopyrimidinring | |
| DK2380892T3 (da) | Imidazothiazolderivat med prolinringstruktur | |
| DK2523960T3 (da) | Heterocykliske carboxylsyrederivater med en 2,5-substitueret oxazolopyrimidinring | |
| DK2325510T3 (da) | Kobling med en ringformet koblingskrop | |
| EP2583965A4 (en) | HETEROCYCLIC RING CONNECTION | |
| HK1178885A1 (en) | Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring | |
| HK1178888A1 (en) | Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring | |
| DK2566838T3 (da) | Forbindelser med en trænote | |
| DK2566849T3 (da) | 8-Hydroxy-quinolinderivater | |
| FR2957385B1 (fr) | Tuyere a col orientable | |
| HK1192240A1 (en) | Carboxylic acid derivatives with an oxazolo[5,4-d]pyrimidine ring [54-d] | |
| DK2465387T3 (da) | Led, især svingled | |
| DK2614333T3 (da) | Følerstiftanordning | |
| DK2519504T3 (da) | Nye sekundære 8-hydroxyquinolin-7-carboxamidderivater | |
| HK1192239A1 (zh) | 具有噁唑並 吡啶環的羧酸衍生物 | |
| HK1192237A1 (en) | Carboxylic acid derivatives with an oxazolo[5,4-d]pyrimidine ring [54-d] | |
| NO346175B1 (no) | Boretårn med selvbærende skall | |
| ITBO20100010U1 (it) | Collare luminoso | |
| TH111954B (th) | แหวน | |
| TH111953B (th) | แหวน |